ProPhase Labs, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

QUARTERLY INFORMATION (UNAUDITED)

QUARTERLY INFORMATION (UNAUDITED)

12 Months Ended

Dec. 31, 2012

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Text Block]

NOTE 12 – QUARTERLY INFORMATION (UNAUDITED)

The following table presents unaudited quarterly financial information for Fiscal 2012 and Fiscal 2011 (in thousands, except per share amounts):

	Quarter Ended
	March 31,			June 30,			September 30,		December 31,
Fiscal 2012
Net sales	$	6,018		$	1,894		$	5,415	$	9,079
Gross profit	$	4,340		$	825		$	3,399	$	5,688
Net income (loss)	$	(688	)	$	(1,930	)	$	1,074	$	453

Basic and diluted earnings (loss) per share:
Net income (loss)	$	(0.05	)	$	(0.13	)	$	0.07	$	0.04

Fiscal 2011
Net sales	$	3,166		$	1,744		$	5,083	$	7,460
Gross profit	$	1,994		$	896		$	3,596	$	4,796
Net income (loss)	$	(1,013	)	$	(976	)	$	1,110	$	(1,831	)

Basic and diluted earnings (loss) per share:
Net income (loss)	$	(0.07	)	$	(0.07	)	$	0.07	$	(0.12	)

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References + Details